beta
Trial Radar AI
Clinical Trial NCT06550193 for Augmented Reality, Virtual Reality is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

AR/VR for Ultrasound-guided Medical Procedures 100 Virtual

Not yet recruiting
Clinical Trial NCT06550193 is an interventional study for Augmented Reality, Virtual Reality and is currently not yet recruiting. Enrollment is planned to begin on 1 September 2025 and continue until the study accrues 100 participants. Led by Stanford University, this study is expected to complete by 1 December 2025. The latest data from ClinicalTrials.gov was last updated on 12 August 2024.
Brief Summary
The study seeks to assess the efficacy of incorporating augmented reality (AR) or virtual reality (VR) technology into ultrasound-guided medical procedures such as regional anesthesia and line placement. By utilizing AR/VR devices, the investigators will improve the ergonomics when using ultrasound to guide procedures. The aims are to enhance visualization of anatomical structures and improve procedural accuracy for ...Show More
Detailed Description
The investigators aim to learn several key insights from this study. Firstly, they hope to determine the extent to which augmented reality (AR) or virtual reality (VR) technology can enhance the precision and accuracy of ultrasound-guided medical procedures, such as regional anesthesia and line placement. This includes evaluating whether AR/VR visualization leads to improved needle placement and reduced complication ...Show More
Official Title

The Use of Augmented Reality (AR) or Virtual Reality (VR) to Enhance the Precision and Accuracy of Ultrasound-guided Medical Procedures

Conditions
Augmented RealityVirtual Reality
Other Study IDs
  • 75204
NCT ID Number
NCT06550193
Start Date (Actual)
2025-09
Last Update Posted
2024-08-12
Completion Date (Estimated)
2025-12
Enrollment (Estimated)
100
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
ultrasound-guided procedure
nerve block
Primary Purpose
Diagnostic
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalAR/VR
AR/VR technology for ultrasound-guided procedures.
Ultrasound-guided procedure using AR/VR technology
Participants will receive the intervention, which involves utilizing AR/VR technology during ultrasound-guided procedures (e.g., regional anesthesia, line placement). All participants will receive standard pre- and post-block or line care as they normally would for the ultrasound-guided procedure.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Procedure success rate (Primary Block)
Document the block result in pre-op, if feasible, or PACU by testing sensory (cold spray) and motor function on all nerves covered by the block
Document the block result pre-operatively (at least 30 min following block completion), or within one hour upon arriving to PACU
Post-operative opioid consumption
Morphine milligram equivalents (MME) will be measured post-operatively
12 hours after surgery
Post-operative pain scores
Trend pain scores on 11-point NRS scale (from 0 to 10) following the procedure
12 hours after surgery
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Clinician satisfaction
A short survey will be utilized to gather data on clinicians' perceptions of the ease of use, effectiveness, and overall experience with AR/VR tools compared to traditional methods.
Within 24 hours of block completion
Procedure duration
Time of procedure from initial needle insertion to needle removal will be calculated
During the procedure
Needle pass/redirection
The number of times a clinician must remove the needle from the patient completely and reattempt will be calculated.
During the procedure
Needle visualisation
A subjective score will be assessed on a short survey to clinicians.
Within 24 hours of block completion
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • adult patients presenting for ultrasound-guided procedures, with ASA physical status I, II, or III.

  • pregnancy
  • incarceration
  • BMI >35
Stanford University logoStanford University665 active studies to explore
Study Responsible Party
Jean-Louis Horn, Principal Investigator, Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University
Study Central Contact
Contact: Jean-Louis Horn, MD, 5033811645, [email protected]
Contact: Ksenia (kasimova), MD, 6507889458, [email protected]
1 Study Locations in 1 Countries

California

Stanford University, Stanford, California, 94305, United States
Ksenia Kasimova, MD, Contact, 650-788-9458, [email protected]
Jean Louis-Horn, MD, Principal Investigator